epigenetic reprogramming – Talk Bio

Actionable Insights Powered by AI

Brian Armstrongs NewLimit raises a $130M Series B, laying out road map for anti-aging drugs

3 days ago talkbio0Tagged Brian Armstrong, CEO, Coinbase, epigenetic reprogramming, genetic cell, healthy lifespan, Kleiner, NewLimit, Perkins, Series B

NewLimit, Brian Armstrong, Coinbase CEO, anti-aging drugs, epigenetic reprogramming, Series B funding, Kleiner Perkins, genetic cell programming, healthy lifespan extension